Answers are grounded in this paper and cite their sources.
Salmonella Typhimurium, a gram-negative, rod-like bacterium and one of the four main causes of diarrhea worldwide. Hosts exert several mechanisms to destroy them, including immune cell activation, phagosome acidification and the production of reactive oxygen species. It has several secretion systems (type I, III, V, VI) that help it circumvent host defenses, facilitating its colony formation, survival and replication within the host. Among the diverse types of secretion systems, the type III plays important roles. Salmonella has evolved unique strategies to exploit immune cells, such as Salmonella -containing vacuoles, to travel undetected in the body. It reprograms macrophage metabolism towards the Warburg effect to enhance intracellular replication and virulence, ultimately leading to the late induction of apoptosis in infected phagocytes, thereby facilitating their further spread in healthy tissues. It escapes the neutrophil-mediated barricade by generating a high-affinity zinc transporter that bypasses the calprotectin-mediated chelation of zinc. They alter immune signaling pathways in neutrophils, leading to the reduction of proinflammatory cytokines. Salmonella survives the neutrophil respiratory burst via different mechanisms. After bacterial internalization by dendritic cells, the bacteria release several factors that induce cell death. They impair T cell proliferation and compete with the resident microbiota for survival. In our review, we elaborated on the pathogenesis of Salmonella Typhimurium and the pathways involved in the bacterium’s immune evasion. Several proteins, including the effectors SipA, SopE2, SpvC and SpvD, the SPI-1 translocon proteins SipB and SipC, as well as the adhesin BapA, contribute to intestinal invasion and systemic dissemination of Salmonella Typhimurium. Besides their virulence, they can induce drug resistance. Resistance to a wide range of antibiotics has been reported, and several mechanisms are associated with it: upregulation of resistance genes (e.g., sul 1, tet A, bla TEM) via horizontal gene transfer or clonal spread; regulation of efflux pumps such as AcrAB-TolC and ompF; and enzymatic degradation of the drugs. Understanding the actions of these effector proteins of Salmonella Typhimurium, especially their interactions with host cells, can further enrich our knowledge of intracellular pathogenesis and its manipulation to incapacitate the host immune system. In addition, it will provide potent targets for the treatment of AMR.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: